New source of income for horticultural sector
Phytonext examines cultivation and production of natural malaria medication
The Phytonext technology makes it possible to gain quality substances from plants under mild conditions. Currently Artemisinin is used in medicines as a semi-synthesized raw material. Phytonext wants to examine whether the substance can also be naturally gained from the plant and how this will effect the functioning of the substance. The natural substance is really sensitive, that's why it's interesting to treat it with the mild extraction technology.
Opportunities for Dutch horticulture
Sweet wormwood doesn't grow in the Netherlands, so the outcome of this examination can offer possibilities for the horticulture. Instead of growing produce for consumers, growers could grow raw materials for the pharmaceutical industry. Because of the current overcapacity and declining profitability, this is a realistic change for a new source of income for this industry. Part of this examination is to find out if growers are interested in this way of cultivation. If so, these growers could contact Phytonext.
Market potential
With the final result of the examination, Phytonext will focus on the pharmaceutical market for malaria medicines. This market has potential because, according to the World Health Organization, artemisinin combination therapy (ACT) is the perfect cure for malaria. Because of the high costs and the fluctuating availability, large scale production with a high percentage yield at a lower price could offer new perspectives.
For more information
Phytonext
+31 (0) 317 466 265
[email protected]
